A detailed history of Hummer Financial Advisory Services Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Hummer Financial Advisory Services Inc holds 8,200 shares of ABBV stock, worth $1.59 Million. This represents 1.22% of its overall portfolio holdings.

Number of Shares
8,200
Previous 8,300 1.2%
Holding current value
$1.59 Million
Previous $1.51 Million 6.95%
% of portfolio
1.22%
Previous 1.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $15,479 - $18,076
-100 Reduced 1.2%
8,200 $1.41 Million
Q1 2024

Apr 11, 2024

BUY
$159.82 - $182.1 $41,553 - $47,346
260 Added 3.23%
8,300 $1.51 Million
Q1 2023

Apr 10, 2023

BUY
$144.61 - $166.54 $28,922 - $33,308
200 Added 2.55%
8,040 $1.28 Million
Q2 2022

Jul 11, 2022

SELL
$137.62 - $174.96 $27,524 - $34,992
-200 Reduced 2.49%
7,840 $1.2 Million
Q1 2022

Apr 11, 2022

BUY
$131.98 - $163.75 $84,467 - $104,800
640 Added 8.65%
8,040 $1.3 Million
Q4 2021

Jan 19, 2022

SELL
$107.43 - $135.93 $68,755 - $86,995
-640 Reduced 7.96%
7,400 $1 Million
Q1 2021

Apr 14, 2021

BUY
$102.3 - $112.62 $10,230 - $11,262
100 Added 1.26%
8,040 $870,000
Q4 2020

Jan 27, 2021

SELL
$80.49 - $108.67 $16,097 - $21,734
-200 Reduced 2.46%
7,940 $851,000
Q3 2020

Oct 16, 2020

SELL
$85.91 - $100.83 $34,364 - $40,332
-400 Reduced 4.68%
8,140 $713,000
Q2 2020

Jul 06, 2020

BUY
$73.37 - $98.18 $7,337 - $9,818
100 Added 1.18%
8,540 $838,000
Q1 2020

Apr 20, 2020

BUY
$64.5 - $97.79 $12,900 - $19,558
200 Added 2.43%
8,440 $643,000
Q4 2019

Feb 10, 2020

BUY
$72.13 - $90.25 $594,351 - $743,660
8,240 New
8,240 $730,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Hummer Financial Advisory Services Inc Portfolio

Follow Hummer Financial Advisory Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hummer Financial Advisory Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hummer Financial Advisory Services Inc with notifications on news.